Autoimmune Nephrology Treatment and Follow-up

Nephrology focuses on diagnosing and treating kidney diseases. The kidneys filter waste, balance fluids, regulate blood pressure, and manage acute and chronic conditions.

Treatment and Follow-up for Autoimmune Kidney Diseases

The treatment and follow-up of autoimmune kidney diseases require a coordinated approach that balances aggressive disease control with long‑term organ preservation. This page is designed for patients and families navigating complex renal conditions such as lupus nephritis, IgA nephropathy, and ANCA‑associated vasculitis, as well as for international visitors seeking world‑class care at Liv Hospital. Did you know that early, targeted therapy can reduce the risk of end‑stage renal disease by up to 40%? Here we outline the full continuum of care—from initial assessment through personalized medication regimens, multidisciplinary coordination, and ongoing monitoring—so you can understand each step of your journey.

Our experts combine the latest evidence‑based protocols with state‑of‑the‑art facilities, ensuring that every patient receives a treatment plan tailored to their unique disease activity, lifestyle, and travel needs. Whether you are planning a short‑term visit for a kidney biopsy or a longer stay for intensive immunotherapy, the information below will guide you through what to expect at each stage of your treatment and follow‑up pathway.

Understanding Autoimmune Kidney Diseases and Treatment Goals

Common Autoimmune Conditions Affecting the Kidneys

Autoimmune nephrology focuses on disorders where the immune system mistakenly attacks renal tissue. The most frequently encountered diseases include:

• Lupus nephritis – a manifestation of systemic lupus erythematosus.
• IgA nephropathy – characterized by IgA deposits in the glomeruli.
• ANCA‑associated vasculitis – includes granulomatosis with polyangiitis and microscopic polyangiitis.
• Membranous nephropathy – often linked to autoantibodies against PLA2R.
• Anti‑GBM disease – rapid progressive glomerulonephritis caused by antibodies against the glomerular basement membrane.

The overarching treatment and follow‑up objectives are to suppress immune activation, preserve renal function, and prevent irreversible scarring.

Initial Assessment and Diagnostic Workup

Key Laboratory and Imaging Studies

Accurate diagnosis sets the foundation for effective therapy. The initial workup typically includes:

• Complete blood count (CBC) and differential.
• Serum creatinine, eGFR, and electrolytes.
• Urinalysis with protein quantification.
• Autoantibody panels (ANA, anti‑dsDNA, ANCA, anti‑GBM, anti‑PLA2R).
• Complement levels (C3, C4).
• Renal ultrasound or MRI to assess size and vascular flow.
• Kidney biopsy for histologic classification when non‑invasive tests are inconclusive.

These investigations not only confirm the diagnosis but also help stratify disease activity, which directly influences the intensity of treatment and follow‑up.

Pharmacologic Treatment Strategies

Immunosuppressive Agents and Biologic Therapies

Medication regimens are tailored to disease severity, organ involvement, and patient tolerance. Core drug categories include:

• Corticosteroids – rapid control of inflammation; tapered over weeks to months.
• Antimetabolites (mycophenolate mofetil, azathioprine) – maintenance of remission.
• Cyclophosphamide – induction therapy for severe or rapidly progressive disease.
• Rituximab – B‑cell depletion, especially effective in lupus nephritis and ANCA‑vasculitis.
• Calcineurin inhibitors (tacrolimus, cyclosporine) – adjunctive agents for refractory proteinuria.

Choosing the right combination is a dynamic process that evolves with each follow‑up visit.

Regular laboratory monitoring, dose adjustments, and patient education are integral components of the treatment and follow‑up framework, ensuring efficacy while minimizing toxicity.

Personalized Treatment Planning and Multidisciplinary Care

The Role of a Coordinated Care Team

Autoimmune kidney disease rarely responds to a single‑specialist approach. At Liv Hospital, a multidisciplinary team collaborates to deliver seamless treatment and follow‑up:

• Nephrologist – leads disease assessment, medication selection, and renal monitoring.
• Rheumatologist – addresses systemic autoimmune activity and extra‑renal manifestations.
• Pathologist – interprets kidney biopsy findings to refine prognosis.
• Pharmacist – ensures safe drug interactions and patient counseling.
• Nutritionist – designs renal‑friendly diets that support recovery.
• Psychologist or Psychiatrist – provides mental‑health support for chronic illness stress.

This collaborative model enables rapid response to changes in disease activity and aligns therapeutic goals with patient preferences.

Through this integrated approach, each follow‑up visit becomes an opportunity to reassess goals, reinforce adherence, and modify the plan as needed.

Monitoring, Follow-up Schedule, and Early Detection of Relapse

Structured Visit Timeline and Laboratory Panel

Consistent monitoring is the cornerstone of successful treatment and follow‑up. A typical schedule may look like:

• Weeks 0–2: Baseline labs, medication tolerance check.
• Weeks 4, 8, 12: Serum creatinine, urine protein, complete blood count.
• Months 6 and 12: Repeat autoantibody panels, complement levels, imaging if indicated.
• Every 6 months thereafter: Full renal panel and clinical assessment.

Any deviation from expected trends—such as rising creatinine, new proteinuria, or resurgence of autoantibodies—triggers an immediate review of the therapeutic regimen.

Liv Hospital’s international patient coordinators assist with scheduling, translation of lab results, and virtual follow‑up options for patients who have returned home, ensuring continuity of care across borders.

Lifestyle Adjustments and Supportive Therapies

Diet, Exercise, and Mental Well‑being

Beyond medication, lifestyle factors play a pivotal role in sustaining remission. Recommendations include:

• Renal‑friendly diet – limit sodium to < 2 g/day, moderate protein intake (0.8 g/kg), and avoid high‑potassium foods if hyperkalemia is a risk.
• Regular aerobic activity – 150 minutes per week of moderate exercise to support cardiovascular health.
• Stress‑reduction techniques – mindfulness, yoga, or counseling to mitigate disease‑related anxiety.
• Vaccinations – pneumococcal and influenza vaccines before initiating high‑dose immunosuppression.
• Smoking cessation – reduces progression of renal damage.